#GujaratGas Huge volume on weekly, stock looks headed to 780 levels next.

More from Dare2Dream
Around 73 / 74 - is the first target - next targets around 110.
Remember :Keeping a stop is always important if one is trading.
@caniravkaria https://t.co/ViHbzJTfQ6

#BHEL looks good for targets of 74+ https://t.co/jrRyXc5FLL pic.twitter.com/KWkzeHSs0D
— Dare2Dream (@Dare2Dr10109801) May 6, 2021

Good morning & thank you everyone for ur wishes & blessings\U0001f64f
— Nirav S. Karia (@caniravkaria) June 19, 2021
Feeling better now as took Dolo 650 but my hand is paining a lot. (huge consumption of Dolo 650 which is manufactured by Micro Labs Ltd unlisted\U0001f600).
But one mentioned in image is really worth studying \U0001f4da\U0001f4d6 ahead \U0001f64f https://t.co/yyrkNyRGAx pic.twitter.com/MijZmCXPMQ
More from Gujaratgas
#GUJGASLTD (2 hours): -687.5 CMP, with support If 680 holds, then 730/800 is on the way :)
#Disclaimer:- View shared is for educational purposes only. Conduct your due diligence before making any trading/investment decisions.
@caniravkaria @nishkumar1977 https://t.co/IoIa9TASCm

Gujarat Gas.... CMP 700...
— Nirav S. Karia (@caniravkaria) September 3, 2021
Baby \U0001f37c \U0001f425 steps \U0001fa9c
Request views and guidance from experts \U0001f64f
(Purely for educational purposes) pic.twitter.com/Eidd0AHZlz
Targets Achieved as mentioned in last tweet after pyramiding the trade.
Added upside targets if you are holding for longer time frame.
@Puretechnicals9
@ca_mehtaravi
@jainchintan67
Who bought this? https://t.co/Mu3P73Z5tR

Update Chart of #GujaratGas
— Market Learner \U0001f3af (@MarketLearner7) June 3, 2021
Shared Fibonacci view too
Hope you like It.
Already up 8% from last tweet.@Puretechnicals9 @rohanshah619 @ca_mehtaravi https://t.co/mLJlsjRA5w pic.twitter.com/GyREKtB53M
You May Also Like
Five billionaires share their top lessons on startups, life and entrepreneurship (1/10)
I interviewed 5 billionaires this week
— GREG ISENBERG (@gregisenberg) January 23, 2021
I asked them to share their lessons learned on startups, life and entrepreneurship:
Here's what they told me:
10 competitive advantages that will trump talent (2/10)
To outperform, you need serious competitive advantages.
— Sahil Bloom (@SahilBloom) March 20, 2021
But contrary to what you have been told, most of them don't require talent.
10 competitive advantages that you can start developing today:
Some harsh truths you probably don’t want to hear (3/10)
I\u2019ve gotten a lot of bad advice in my career and I see even more of it here on Twitter.
— Nick Huber (@sweatystartup) January 3, 2021
Time for a stiff drink and some truth you probably dont want to hear.
\U0001f447\U0001f447
10 significant lies you’re told about the world (4/10)
THREAD: 10 significant lies you're told about the world.
— Julian Shapiro (@Julian) January 9, 2021
On startups, writing, and your career:
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj

@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
